Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

SeraCare Life Sciences, Inc. announced today that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare’s growing customer base in the life sciences industry.

9 Jan 2010

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Acetylon Pharmaceuticals, Inc. announced today that it has closed on a $2 million investment from a new undisclosed private investor to bring its total financing to $9.25 million. This new investment will convert to stock in the next substantial round of preferred equity financing.

9 Jan 2010

NexMed updates corporate activities

NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today provided an update on ongoing corporate activities and the status of the Company’s NASDAQ listing.

9 Jan 2010

FDA yet to review MannKind’s NDA for insulin therapy

MannKind Corporation announced that it was informed today by the Food and Drug Administration that the FDA will not be able to complete the review of MannKind’s new drug application (NDA) for its ultra rapid-acting insulin therapy by the action date of January 16, 2010.

9 Jan 2010

ChiroCode Institute and Avazzia jointly promote advanced technology devices

ChiroCode Institute and Avazzia will jointly promote advanced technology devices that help chiropractors and other caregivers manage their patients' chronic pain. The Avazzia BEST Pro Sport device combines microcurrent transcutaneous stimulation with somatic bio-feedback to provide improved results while making obsolete existing TENS devices.

9 Jan 2010

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.

9 Jan 2010

Sybaritic to stop production and distribution of medical devices

Sybaritic Inc., a medical device maker, has agreed to stop producing and distributing its medical products used in laser surgery, dermatology, and spa treatments until it is in compliance with FDA quality standards.

8 Jan 2010

Synta Pharmaceuticals announces pricing of public offering of shares

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock at a price to the public of $4.50 per share for gross proceeds of approximately $25 million.

8 Jan 2010

3Sbio submits registrational clinical trial application for Feraheme injection

3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a registrational clinical trial to the Chinese State Food and Drug Administration ("SFDA") for Feraheme (ferumoxytol) Injection for intravenous use.

8 Jan 2010

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company specializing in the development and GMP manufacture of monoclonal antibodies, fusion proteins and other therapeutic protein products, and Iconic Therapeutics, a company focused on the development of treatments for wet adult macular degeneration (wet AMD) and other ophthalmic diseases, today announced the completion of the manufacture of the first GMP lot of hI-con1(TM) recombinant Fc-Factor VII fusion protein.

8 Jan 2010

Genzyme enters into mutual cooperation agreement with Relational Investors

Genzyme Corporation and San-Diego based institutional investor Relational Investors LLC announced today that they have entered into a mutual cooperation agreement. Relational, a $6 billion private investment fund, began investing in Genzyme shares in late 2008 and currently owns approximately 4 percent of the company’s common stock.

8 Jan 2010

China Medicine enters into Stock Subscription Agreement with OEP

China Medicine Corporation ("China Medicine" or "the Company"), primarily a leading distributor and a developer of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other nutriceuticals today announced that it has entered into a Stock Subscription Agreement for an equity private placement (the "Subscription Agreement") with One Equity Partners ("OEP"), the global private equity investment arm of JPMorgan Chase & Co.

7 Jan 2010

U.S. Marshals seize all FDA-regulated foods susceptible to contamination by rodents and insects

At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized bulk restaurant food productat Won Feng Trading Company, a food processor and warehouse in Nashville, Tenn. The products are adulterated under the Federal Food, Drug, and Cosmetic Act because they have been held under unsanitary conditions whereby they may have become contaminated with filth.

7 Jan 2010

Ceragenix Pharmaceuticals and BioPro Pharmaceutical enter into agreement to commercialize EpiCeram

Ceragenix Pharmaceuticals, Inc. (“Ceragenix”), a medical device company focused on infectious disease and dermatology today announced that it has entered into an exclusive distribution and supply agreement (the “Agreement”) with BioPro Pharmaceutical, Inc. (“BioPro”), to commercialize EpiCeram®, a prescription topical cream for treating atopic dermatitis and other dry skin conditions, in Hong Kong and Taiwan (the “Territories”).

7 Jan 2010

Educational sessions and special workshops highlight advancements in molecular imaging

SNM's Conjoint Mid-Winter Meetings, Jan. 27-Feb. 2, 2010, in Albuquerque, N.M., will bring together four scientific meetings under one umbrella. The meeting, which provides attendees with the opportunity to earn up to 25 continuing education credits, will highlight the latest advancements in molecular imaging and nuclear medicine. The educational sessions will conclude with special workshops on nanomedicine and clinical trials.

7 Jan 2010

Microbia creates carotenoids for food ingredient and nutritional supplement markets

Microbia, Inc., an emerging leader in the production of sustainable specialty ingredients and biomaterials, today announced that it has achieved an important milestone in creating its line of naturally derived carotenoids for the food ingredient and nutritional supplement markets.

7 Jan 2010

Drug companies still under great and growing pressure to bring more products to market

Although drug developers are improving R&D efficiency, in part by terminating more unpromising drugs earlier in development, their continued success will depend on how well they partner with other firms at specific points on the development spectrum, according to the Tufts Center for the Study of Drug Development.

7 Jan 2010

Scientists use NIR to predict how quickly pills dissolve in body

Scientists at the University of Maryland, Baltimore have successfully used near-infrared spectroscopy (NIR) -- a method already used to test farm product quality -- to predict how quickly pills dissolve in the body.

7 Jan 2010

BC Tech's new, miniature single use video camera can help reduce healthcare costs

BC Tech, a medical product development and manufacturing company, has launched a miniature single use video camera that can be integrated into medical devices to improve safety and help reduce healthcare costs.

7 Jan 2010

DBA Analytical to host a 2-day training course on dietary supplements

DBA Analytical, an NSF International company, which provides a full range of compliance services for FDA regulated industries, will host a 2-day training course on 21 CFR 111, the Current Good Manufacturing Practices (cGMPs) in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements.

6 Jan 2010

Manufacturing News and Research

Further Reading

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

NexMed updates corporate activities

FDA yet to review MannKind’s NDA for insulin therapy

ChiroCode Institute and Avazzia jointly promote advanced technology devices

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Sybaritic to stop production and distribution of medical devices

Synta Pharmaceuticals announces pricing of public offering of shares

3Sbio submits registrational clinical trial application for Feraheme injection

Laureate Pharma and Iconic Therapeutics complete manufacturing hI-con1 recombinant Fc-Factor VII fusion protein

Genzyme enters into mutual cooperation agreement with Relational Investors

China Medicine enters into Stock Subscription Agreement with OEP

U.S. Marshals seize all FDA-regulated foods susceptible to contamination by rodents and insects

Ceragenix Pharmaceuticals and BioPro Pharmaceutical enter into agreement to commercialize EpiCeram

Educational sessions and special workshops highlight advancements in molecular imaging

Microbia creates carotenoids for food ingredient and nutritional supplement markets

Drug companies still under great and growing pressure to bring more products to market

Scientists use NIR to predict how quickly pills dissolve in body

BC Tech's new, miniature single use video camera can help reduce healthcare costs

DBA Analytical to host a 2-day training course on dietary supplements

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News